Beclin-1 is frequently monoallelically deleted in breast cancer and interacts with ATG14 to trigger apoptosis inhibition in breast cancer, leading to cancer progression and chemotherapy resistance [24]. This evidence concerns the gene ATG14 and breast carcinoma.